Upexi, Inc (UPXI) FinancialsUPXIFinancialUpexi, Inc

Upexi, Inc (UPXI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Contract manufactured, accounting for 70.8% of total sales, equivalent to $744.32K. Other significant revenue streams include Internally manufactured and Purchased as finished goods. Understanding this composition is critical for investors evaluating how UPXI navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Upexi, Inc maintains a gross margin of 93.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -127.67%, while the net margin is -2399.42%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively UPXI converts its operational activities into shareholder value.

In the context of the broader market, UPXI competes directly with industry leaders such as IBIO and LFVN. With a market capitalization of $84.84M, it holds a leading position in the sector. When comparing efficiency, UPXI's gross margin of 93.11% stands against IBIO's N/A and LFVN's 77.97%. Such benchmarking helps identify whether Upexi, Inc is trading at a premium or discount relative to its financial performance.

Upexi's total revenue for Q1 2026 was $9,239,745, a substantial increase compared to previous quarters. The gross margin has improved significantly, reaching 87.97% in Q1 2026, indicating effective cost management and profitability potential.